Company intelligence / Profile preview

BioViotica

Dransfeld, Germanycaltagmedsystems.co.uk ↗

Ownership: Private
Development stage: Other

Overview

BioViotica was dedicated to the discovery, fermentation, and characterization of rare biologically active natural products, primarily for use as research reagents in academic or early discovery pharmaceutical applications. Its compound portfolio is now fully incorporated as a brand under AdipoGen Life Sciences following acquisition in 2024.

Modalities: Small moleculeNatural product
Industry: Drug Discovery Services

Partnerships

AdipoGen Life Sciences

Beyond the preview

Go deeper on BioViotica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioViotica.

Explore the full profile